Marketing-authorisation holder
Wyeth Cons
5 medicines in 1 country, as authorisation holder.
Loading…
Marketing-authorisation holder
5 medicines in 1 country, as authorisation holder.
One free account for the Prognia apps: Ward to study, Osler for clinical answers with their sources, and the network to find your colleagues.
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
Every medicine in the registers under its name, current ones first.
5 medicines
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| BRONITIN MIST0.3mg/inh · Aerosol, metered | Epinephrine | United States | Not marketed | 1967 |
| DIMETANE12mg | 8mg · Tablet, extended release | Brompheniramine | United States | Not marketed | 1957 |
| DIMETANE4MG · Tablet | Brompheniramine | United States | Not marketed | 1957 |
| ORUDIS KT12.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · Tablet | Ketoprofen | United States | Not marketed | 1995 |
| PRIMATENE MIST0.125mg/inh | 0.2mg/inh · Aerosol, metered | Epinephrine | United States | Marketed | 1967 |
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| United States | 5 | 5 | 0 | CompaniesAll medicines |
The active substances in most of its medicines.
Compiled by Prognia from the public medicine and company registers below. Logos are not used.
Source: U.S. FDA, Drugs@FDA / openFDA. FDA does not endorse this site.
Licence: Public domain (U.S. Government work)
Report an error or request removalCorrections from the company itself are welcome.
Keep Wyeth Cons’s medicines accurate on Prognia, see how professionals use them and answer what they ask. A 20-minute call, in English.
Book a callOther companies in the same group.